Pramana Pharmaceuticals
PrivateLast Round
Grant
Jan 7, 2026
Total Funding Raised
$1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pramana Pharmaceuticals is a biotechnology company that develops next-generation oral small-molecule therapies targeting metabolic signaling pathways for neurodegenerative and cardio-metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pramana Pharmaceuticals Comparables
Compare Pramana Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kallyope | 81% | |
| Muna Therapeutics | 81% | |
| T3D Therapeutics, Inc. | 78% |
Pramana Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 7, 2026 |
Pramana Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartUp Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
$1M grant received from Alzheimer's Association and StartUp Health.
Pramana Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pramana Pharmaceuticals's valuation, stock price, and market status.
Is Pramana Pharmaceuticals a public or private company?
Pramana Pharmaceuticals is a private company.
What is the current stock price of Pramana Pharmaceuticals?
Pramana Pharmaceuticals is a private company with no public stock price. Caplight tracks Pramana Pharmaceuticals's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Pramana Pharmaceuticals worth (valuation)?
Valuation information for Pramana Pharmaceuticals is not publicly available.
Can I buy Pramana Pharmaceuticals stock?
Pramana Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pramana Pharmaceuticals's last funding round?
Pramana Pharmaceuticals's most recent funding round was Grant on January 7, 2026.
Who are the main investors in Pramana Pharmaceuticals?
Key investors in Pramana Pharmaceuticals include StartUp Health.
Will Pramana Pharmaceuticals IPO soon?
No public IPO plans have been announced for Pramana Pharmaceuticals.
How can I track Pramana Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pramana Pharmaceuticals's secondary market activity and sign up for updates.